share_log

华仁药业:关于腹膜透析液(乳酸盐-G1.5%、G2.5%)取得药品补充申请批准通知书的公告

Huaren Pharmaceutical: Announcement regarding the acquisition of pharmaceutical supplementary application approval for peritoneal dialysis solution (lactate-G1.5%, G2.5%).

Sensex a share ·  Jun 20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more